Elevai Labs Past Earnings Performance
Past criteria checks 0/6
Elevai Labs's earnings have been declining at an average annual rate of -53.5%, while the Personal Products industry saw earnings growing at 12.5% annually. Revenues have been growing at an average rate of 147% per year.
Key information
-53.5%
Earnings growth rate
-46.2%
EPS growth rate
Personal Products Industry Growth | 20.9% |
Revenue growth rate | 147.0% |
Return on equity | -185.7% |
Net Margin | -211.4% |
Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Elevai Labs makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Mar 24 | 2 | -5 | 5 | 0 |
31 Dec 23 | 2 | -4 | 4 | 0 |
30 Sep 23 | 1 | -4 | 4 | 0 |
30 Jun 23 | 1 | -4 | 3 | 0 |
31 Mar 23 | 1 | -3 | 2 | 0 |
31 Dec 22 | 1 | -2 | 2 | 0 |
31 Dec 21 | 0 | -1 | 1 | 0 |
Quality Earnings: ELAB is currently unprofitable.
Growing Profit Margin: ELAB is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: ELAB is unprofitable, and losses have increased over the past 5 years at a rate of 53.5% per year.
Accelerating Growth: Unable to compare ELAB's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: ELAB is unprofitable, making it difficult to compare its past year earnings growth to the Personal Products industry (7.5%).
Return on Equity
High ROE: ELAB has a negative Return on Equity (-185.74%), as it is currently unprofitable.